Publicacions en col·laboració amb investigadors/es de Gustave Roussy Cancer Campus (13)

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

2018

  1. Genomic amplifications and distal 6q loss: Novel markers for poor survival in high-risk neuroblastoma patients

    Journal of the National Cancer Institute, Vol. 110, Núm. 10

2015

  1. Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

    Clinical Cancer Research, Vol. 21, Núm. 8, pp. 1904-1915

2013

  1. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

    European Journal of Cancer, Vol. 49, Núm. 17, pp. 3671-3679

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

  2. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    British Journal of Cancer, Vol. 105, Núm. 12, pp. 1940-1948

2009

  1. Histological heterogeneity of Ewing's sarcoma/PNET: An immunohistochemical analysis of 415 genetically confirmed cases with clinical support

    Virchows Archiv, Vol. 455, Núm. 5, pp. 397-411

  2. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

    The Lancet Oncology, Vol. 10, Núm. 7, pp. 663-671

1989

  1. Fibroblast and Myofibroblast Participation in Malignant Fibrous Histiocytoma (MFH) of Bone: Ultrastructural Study of Eight Cases with Immunohistochemical Support

    Pathology Research and Practice, Vol. 184, Núm. 6, pp. 582-590

1987

  1. Giant cell tumors of maxilla

    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris, Vol. 104, Núm. 4, pp. 251-257

  2. S-100 protein positive cells in nasopharyngeal carcinoma (NPC): Absence of prognostic significance - A clinicopathological and immunohistochemical study of 40 cases

    Virchows Archiv A Pathological Anatomy and Histopathology, Vol. 411, Núm. 3, pp. 233-237

1984

  1. FIBROHISTIOCYTOMES MALINS DES TISSUS MOUS. ANATOMIE PATHOLOGIQUE

    Archives d'Anatomie et de Cytologie Pathologiques, Vol. 32, Núm. 4, pp. 202-207